PATENT CLAIM ANALYSIS

Application Number: 15960392
Application Type: Utility
Filing Date: 2018-04
Publication Date: 2018-08
Patent Classification: ["514", "282000"]

Abstract:
The embodiments provide a percutaneous absorption composition for a basic medicament having improved transdermal absorbability. The percutaneous absorption composition comprises a sorbic acid and/or a metal sorbate as a percutaneous absorption promotor. The molar ration of the sorbic acid and/or the metal sorbate to the basic medicament is 0.5-2.5. The composition of the present disclosure may further comprise a basic component.

Claim (Index 13):
The method according to  claim 9 , wherein the basic component comprises at least one of an organic basic component, an inorganic basic component, and a salt of a strong base.

Metadata:
- Claim Count in Document: 13.0
- Percentile: 91.0
- Lexical Diversity: 1.80556
- Patent Class: 514.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['15279210', '15279272', '11883736', '12457410', '14568364']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7616984638698998
- 35 USC 102 Novelty (BERT): 0.5536787968855785
- Combined Prediction Score: 0.7408964971714677
- Mean Citation Score: 231.867804
- Max Citation Score: 425.09134000000006
- Similarity Product: 311.5777802924872

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test